OIM
MNTA

Oracle Investment Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Oracle Investment Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-147,895
Closed -$2.25M – 30
2015
Q1 		$2.25M Buy
+147,895
New +$1.92M 0.29% 27

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Oracle Investment Management's MNTA Position: Q2 2015 in Review

Oracle Investment Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q2 2015, closing a stake of 147,895 shares — an estimated $2.25M sold.

Oracle Investment Management first reported a position in MNTA in Q1 2015 and held it in 1 quarter. The position peaked at $2.25M in Q1 2015. 162 funds tracked by Wall St. Rank hold MNTA as of Q2 2015.

  • Oracle Investment Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
  • Oracle Investment Management sold 147,895 Momenta Pharmaceuticals, Inc. shares in Q2 2015, an estimated $2.25M.
  • Oracle Investment Management first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2015 and held it in 1 quarter.
  • Oracle Investment Management's Momenta Pharmaceuticals, Inc. position peaked at $2.25M in Q1 2015.
  • 162 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q2 2015.

Based on Oracle Investment Management's 13F filing for Q2 2015, filed 14 Aug 2015.